177 Lu-WT-7695

N/A

Report date: 2025/11/28 17:54:27
NME

Base Information

Drug Name177 Lu-WT-7695
Drug Alias Name177 Lu-WT-7695
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4] 
Mechanisms of ActionAnti-Carbonic anhydrase IX
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWisconsin Alumni Research FoundationSK Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWARF TherapeuticsShine Technologies LLCSK Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A